Enzalutamide — Dosing in CKD & Dialysis

Enzalutamide (Antineoplastic): renal dosing adjustments, dialyzability (Not studied in the label (no statement on removal by dialysis); enzalutamide is 97% to 98% bound to plasma proteins and N-desmethyl enzalutamide 95% (Xtandi label 12.3), and in one hemodialysis patient their plasma levels were i

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.